Today: 30 June 2026
UnitedHealth trims SEC subsidiary disclosure to 10 — a sharp shift from last year’s 3,100
5 March 2026
1 min read

UnitedHealth trims SEC subsidiary disclosure to 10 — a sharp shift from last year’s 3,100

New York, March 4, 2026, 18:53 EST

  • Exhibit 21.1 in UnitedHealth’s annual report filing shows 10 subsidiaries labeled as “significant.”
  • STAT News reported the company had listed almost 3,100 subsidiaries just a year prior.
  • Investors now have a slimmer view into the insurer’s sprawling corporate structure.

UnitedHealth Group Incorporated has dramatically trimmed down the roster of subsidiaries shown in its annual report, removing thousands of legal entities from what has long served as a key reference point for investors tracking major firms.

Exhibit 21.1 of the company’s Form 10-K—its annual filing with the U.S. Securities and Exchange Commission—lays out the list. For a fast look at which corporate entities fall under the parent and where major operations are booked, this is typically the go-to section.

It matters right now because UnitedHealth’s setup is central to its scale story. UnitedHealthcare handles insurance, while Optum covers health services. Add in the company’s string of clinics, pharmacies and other assets—acquired over years of dealmaking—and you get the full picture.

UnitedHealth’s latest filing shows 10 “significant subsidiaries” as of Dec. 31, 2025. Names on the list: Optum, Inc., United HealthCare Services, Inc., UnitedHealthcare Insurance Company, and UnitedHealthcare, Inc., among others. The company noted in the document that subsidiaries failing to meet the SEC threshold for significance aren’t included. SEC

The SEC’s label “significant subsidiary” applies to any unit that hits key benchmarks for assets, income, or the parent’s invested capital. Translation: these are the businesses with real financial impact—not just every name scattered across the corporate structure.

UnitedHealth’s Exhibit 21.1 wasn’t always this streamlined. In its previous annual report, the company detailed subsidiaries as of Dec. 31, 2024, sprawling across hundreds of pages. The list covered everything from U.S. operations to entities in British Columbia, Colombia, Peru, and more.

STAT News, in a report Wednesday, noted UnitedHealth trimmed its roster of listed subsidiaries drastically—down to just 10 from almost 3,100 last year. STAT argued the move complicates efforts to monitor the company.

This shift doesn’t automatically signal UnitedHealth got rid of the entities. Exhibit 21.1 is just a disclosure section—firms have leeway in deciding what to include, provided they’re still following SEC guidelines.

The slimmer list makes it tougher for investors to pinpoint where acquisitions end up, which units are holding the contracts, and how legal or regulatory risks get spread throughout the company. When a company is already fielding questions about how all its pieces connect, that kind of uncertainty only grows.

UnitedHealth’s filing referred to the group simply as its “significant subsidiaries,” stopping short of offering any further explanation in the exhibit. The company also left out details on what prompted the shift in approach.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Target Hospitality (TH) jumps 152%, analysts flag risks after Q1
    June 30, 2026, 11:15 AM EDT. Target Hospitality (TH) soared 152% to hit $20.42 and a 52-week high after Q1 results came out, but analysts aren't sold. They point to a nearly 30% year-over-year drop in utilized beds, showing demand is still down. Free cash flow margin sits at just 9%, which limits how much the company can reinvest. Falling ROIC hints at thinner growth ahead. Even after the rally, TH trades at a steep 1,433.5× forward P/E, raising questions about valuation. Analysts say investors face risks if they buy or keep holding here.
Ashtead share price: AHT set to disappear from London screens as Sunbelt listing goes live
Previous Story

Ashtead share price: AHT set to disappear from London screens as Sunbelt listing goes live

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 09.03.2026

Go toTop